Vladimir Cejka

8PUBLICATIONS
43CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Numerical modelling and mechanical characterisationRespiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2026
Contemporary Real-World Treatment of Cardiac Transthyretin Amyloidosis with Tafamidis: A Long-Term Multicentre Study.

|Jun 08, 2026
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis.

|Mar 20, 2026
Myocardial work analysis during semi-supine stress echocardiography: exercise response patterns in heart failure patients and controls.

Floran Sahiti, Vladimir Cejka, Gülmisal Güder

|Jun 15, 2024
Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study.

Floran Sahiti, Vladimir Cejka, Lena Schmidbauer

|Jan 11, 2024
Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis-A Clinical Feasibility Study.

Maximilian J Steinhardt, Vladimir Cejka, Mengmeng Chen

|Dec 12, 2023
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.

Kaitlin J Mayne, Natalie Staplin, David F Keane

Pageof 2

Frequent Collaborators

5 joint publications

Caroline Morbach

5 joint publications

Stefan Störk

4 joint publications

Floran Sahiti

2 joint publications

Peter U Heuschmann